Cross Country Healthcare (CCRN) AI Stock Analysis

• Market Cap: $394.76M
• Dividend Yield: N/A
• Average Volume (3M): 398.73K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.14
• Revenue Growth: -22.14%
• EPS Growth: -787.87%
• Country: US
• Employees: 9,605
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.03
• Shares Outstanding: 32,759,953
• 10 Day Avg. Volume: 380,139
• 30 Day Avg. Volume: 398,728
• PEG Ratio: 0.34
• Price to Book (P/B): 1.45
• Price to Sales (P/S): 0.45
• P/FCF Ratio: 5.44
• Enterprise Value/Market Cap: 0.88
• Enterprise Value/Revenue: 0.31
• Enterprise Value/Gross Profit: 1.52
• Enterprise Value/Ebitda: 54.63
• 1Y Price Target: $9.55
• Price Target Upside: 12.49% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 8
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: $10.50 ▲(23.67% Upside)

Cross Country Healthcare's overall stock score is primarily impacted by its financial performance challenges, including declining revenue and profitability issues. The bearish technical indicators further weigh on the score. Valuation concerns, highlighted by a negative P/E ratio, also contribute to the lower score. The termination of the merger adds uncertainty, although the company shows some financial resilience through planned share repurchases.

Positive Factors

Balance Sheet Health

A low debt-to-equity ratio indicates strong financial stability, providing the company with flexibility to invest in growth opportunities and withstand economic downturns.

Cash Flow Generation

Improved cash generation enhances financial resilience, allowing the company to fund operations, invest in strategic initiatives, and return capital to shareholders.

Homecare Staffing Growth

Growth in the Homecare Staffing segment suggests a successful strategy in expanding service offerings, potentially leading to increased market share and revenue stability.

Negative Factors

Declining Revenue

A significant decline in revenue indicates challenges in maintaining market position and could impact long-term profitability and growth prospects.

Profitability Issues

Persistent profitability issues suggest difficulties in cost management and achieving operational efficiency, potentially hindering long-term financial health.

Merger Termination

The failed merger introduces strategic uncertainty and may limit growth opportunities, affecting the company's ability to compete effectively in the market.

Cross Country Healthcare Business Overview & Revenue Model

Company Description

Cross Country Healthcare (CCRN) is a leading provider of healthcare staffing and workforce solutions, specializing in the recruitment and placement of healthcare professionals across various sectors, including nursing, allied health, and physician services. The company operates primarily in the temporary staffing market, offering a range of services such as travel nursing, per diem staffing, and recruitment process outsourcing. With a focus on meeting the dynamic needs of healthcare facilities, CCRN leverages technology and deep industry expertise to deliver high-quality staffing solutions that enhance patient care.

How the Company Makes Money

Cross Country Healthcare generates revenue primarily through its staffing services, which include travel nursing, per diem staffing, and other workforce solutions. The company charges healthcare facilities for the placement of temporary and permanent staff, earning a markup on the salaries of the healthcare professionals it places. Additional revenue streams include recruitment process outsourcing and managed services provider solutions. Significant partnerships with healthcare institutions and organizations enhance its ability to fill staffing needs efficiently. The demand for temporary healthcare staffing, driven by factors such as seasonal fluctuations, increased patient volumes, and workforce shortages, contributes to consistent revenue generation for CCRN.

Cross Country Healthcare Financial Statement Overview

Summary

Cross Country Healthcare faces challenges in revenue growth and profitability, as seen in its income statement. The balance sheet is strong with low leverage, but the negative return on equity indicates inefficiencies. Cash flow generation has improved, but there are concerns about converting income into cash. Overall, the company needs to address profitability and operational efficiency to enhance its financial health.

Income Statement

Cross Country Healthcare's income statement shows a declining trend in revenue with a negative revenue growth rate of -5.46% TTM. The company is struggling with profitability, as indicated by negative net profit and EBIT margins. The gross profit margin remains relatively stable but has decreased slightly over the years. The negative EBIT and net profit margins highlight challenges in managing operational costs and achieving profitability.

Balance Sheet

The balance sheet reflects a strong equity position with a low debt-to-equity ratio of 0.0067 TTM, indicating low leverage and financial stability. However, the return on equity is negative, suggesting inefficiencies in generating returns from equity. The equity ratio is healthy, showing a solid foundation of equity relative to total assets.

Cash Flow

The cash flow statement shows a positive free cash flow growth rate of 33.96% TTM, indicating improved cash generation. However, the operating cash flow to net income ratio is below 1, suggesting potential issues in converting income into cash. The free cash flow to net income ratio is strong, reflecting efficient cash management despite net losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.13B	1.34B	2.02B	2.80B	1.68B	836.42M
Gross Profit	227.58M	274.25M	450.41M	624.46M	375.00M	202.73M
EBITDA	6.33M	16.77M	129.34M	280.06M	154.56M	25.89M
Net Income	-15.68M	-14.56M	72.63M	185.98M	132.00M	-12.96M
Balance Sheet
Total Assets	538.23M	589.25M	679.32M	947.84M	732.81M	356.97M
Cash, Cash Equivalents and Short-Term Investments	99.13M	81.63M	17.09M	3.60M	1.04M	1.60M
Total Debt	2.20M	3.87M	5.27M	157.75M	195.49M	78.00M
Total Liabilities	130.09M	170.29M	205.92M	490.62M	435.28M	202.06M
Stockholders Equity	408.14M	418.96M	473.39M	457.22M	297.53M	154.38M
Cash Flow
Free Cash Flow	45.67M	111.40M	234.52M	125.26M	-92.79M	22.59M
Operating Cash Flow	54.25M	120.12M	248.50M	134.05M	-85.62M	27.20M
Investing Cash Flow	-8.57M	-8.71M	-13.78M	-43.87M	-34.05M	-4.62M
Financing Cash Flow	-10.56M	-46.85M	-221.24M	-87.60M	119.09M	-22.01M

Cross Country Healthcare Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 8.49
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCRN, the sentiment is Negative. The current price of 8.49 is below the 20-day moving average (MA) of 9.87, below the 50-day MA of 11.51, and below the 200-day MA of 13.22, indicating a bearish trend. The MACD of -1.04 indicates Positive momentum. The RSI at 34.03 is Neutral, neither overbought nor oversold. The STOCH value of 32.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCRN.

Cross Country Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CYH	61 Neutral	$502.83M	1.50	―	―	0.74%	―
INNV	57 Neutral	$732.68M	-41.86	-6.86%	―	12.48%	-9.28%
ASTH	56 Neutral	$1.14B	119.95	1.29%	―	68.17%	-85.42%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AMN	50 Neutral	$624.99M	―	-35.90%	―	-11.42%	-617.31%
CCRN	46 Neutral	$394.76M	-46.54	-3.76%	―	-22.14%	-787.87%
AGL	42 Neutral	$298.71M	―	-73.31%	―	5.21%	5.21%

Cross Country Healthcare Corporate Events

Cross Country Healthcare Holds Annual Stockholders Meeting

On December 9, 2025, Cross Country Healthcare held its Annual Meeting of Stockholders where several key proposals were voted on. The stockholders approved the election of directors for a one-year term, ratified the appointment of Deloitte & Touche as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approved the compensation of named executive officers on an advisory basis.

Cross Country Healthcare Ends Merger with Aya Holdings

On December 4, 2025, Cross Country Healthcare announced the termination of its merger agreement with Aya Holdings II Inc. due to the failure to meet the merger’s consummation deadline, partly caused by an extended FTC review period. As a result, Aya Healthcare will pay a $20 million termination fee to Cross Country Healthcare. Despite the setback, Cross Country Healthcare remains focused on its strategic goals, emphasizing its operational resilience and financial strength, and plans to commence share repurchases under its existing $40 million authorization.

Cross Country Healthcare Reports Q3 2025 Financial Results

Cross Country Healthcare announced its financial results for the third quarter of 2025, revealing a consolidated revenue of $250.1 million, a 21% decrease year-over-year. Despite a net loss of $4.8 million, the company reported strong performance in its Homecare Staffing segment, with a 29% revenue growth over the prior year. The company maintained a healthy balance sheet with $99 million in cash and no debt, and positive cash flow from operations of $20 million for the quarter. As the company awaits the completion of its merger with Aya Healthcare, it continues to focus on expanding and renewing contracts, with over $400 million in contract value secured.

Cross Country Healthcare Sets Stockholder Proposal Deadline

On September 25, 2025, Cross Country Healthcare‘s Board of Directors announced that the 2025 Annual Meeting of Stockholders is scheduled for December 9, 2025, unless the pending merger with Aya Healthcare is completed beforehand. If the merger is finalized as expected in the fourth quarter of 2025, Cross Country Healthcare will become a wholly owned subsidiary of Aya Healthcare, and the Annual Meeting will not occur. The company has set an October 10, 2025, deadline for stockholder proposals and nominations, with specific guidelines for submission.